Trisomy 1q and deletion of 11q in acute myelofibrosis

Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes.

Leukemia·2007

Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies.

Histopathology·2006

Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia.

Leukemia·2004

Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2004

Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.

Annals of hematology·2003

Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial.

Leukemia·2003

Lactoferrin as a Natural Modulator of Immunity and Iron Homeostasis: A Review of Current Knowledge.

Acta haematologica·2026

Clinical Features and Prognostic Impact of Splicing Factor Mutations and Their Co-Mutations in Acute Myeloid Leukemia.

Acta haematologica·2026

Oral Versus Intravenous Hypomethylating Agents in Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Multicenter Real-World Toxicity Comparison.

Acta haematologica·2026

Navigating the Immune Landscape: Balancing Efficacy and Toxicity of B-Cell Maturation Antigen-Targeting Agents in Multiple Myeloma.

Acta haematologica·2026

Global Disparities in Multiple Myeloma Quality of Care Indicators and Their Association with Socioeconomic Development and Behavioral Risk Factors: An Analysis of GBD 2021 Data.

Acta haematologica·2026

Post-Marketing Safety of the Menin Inhibitor Revumenib: A Bayesian Disproportionality Analysis of a National Database.

Acta haematologica·2026

Association between IRAK1 gene rs1059703 polymorphism and rheumatoid arthritis risk.

Biomarkers in medicine·2026

A breast clinical scoring system to identify women with Idiopathic granulomatous Mastitis.

Breast cancer research and treatment·2026

Temporal Trends in Invasive Pulmonary Aspergillosis Among Critically Ill Patients: Serum Galactomannan Testing Intensity and Host Risk Status.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Cardiomyocyte-derived IL-30 improves cardiac repair by reducing splenic germinal center activation after myocardial infarction.

Basic research in cardiology·2026

Genomic and immune profiling characterizes immune heterogeneity and a TIGIT-associated subtype in intrahepatic cholangiocarcinoma.

Hepatology communications·2026

Jeffrey's Insights: Next-generation sequencing for primary immunodeficiency diagnosis, 2019-2025.

Journal of human immunity·2026

Related Experiment Videos

Trisomy 1q and deletion of 11q in acute myelofibrosis

Related Concept Videos

Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes.

Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies.

Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia.

Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.

Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.

Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial.

Lactoferrin as a Natural Modulator of Immunity and Iron Homeostasis: A Review of Current Knowledge.

Clinical Features and Prognostic Impact of Splicing Factor Mutations and Their Co-Mutations in Acute Myeloid Leukemia.

Oral Versus Intravenous Hypomethylating Agents in Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Multicenter Real-World Toxicity Comparison.

Navigating the Immune Landscape: Balancing Efficacy and Toxicity of B-Cell Maturation Antigen-Targeting Agents in Multiple Myeloma.

Global Disparities in Multiple Myeloma Quality of Care Indicators and Their Association with Socioeconomic Development and Behavioral Risk Factors: An Analysis of GBD 2021 Data.

Post-Marketing Safety of the Menin Inhibitor Revumenib: A Bayesian Disproportionality Analysis of a National Database.

Association between IRAK1 gene rs1059703 polymorphism and rheumatoid arthritis risk.

A breast clinical scoring system to identify women with Idiopathic granulomatous Mastitis.

Temporal Trends in Invasive Pulmonary Aspergillosis Among Critically Ill Patients: Serum Galactomannan Testing Intensity and Host Risk Status.

Cardiomyocyte-derived IL-30 improves cardiac repair by reducing splenic germinal center activation after myocardial infarction.

Genomic and immune profiling characterizes immune heterogeneity and a TIGIT-associated subtype in intrahepatic cholangiocarcinoma.

Jeffrey's Insights: Next-generation sequencing for primary immunodeficiency diagnosis, 2019-2025.

Related Experiment Videos

Trisomy 1q and deletion of 11q in acute myelofibrosis

Related Concept Videos

Related Articles